[Experimental principles and clinical use of electrolyte carrier compounds. 4. The normalizing effect of potassium and magnesium asparaginate on an atypical substrate balance appearing in cancer patients. The importance of the problem for the host organism].
D001216:Asparagine / Q000031:analogs & derivatives; D004573:Electrolytes; D006801:Humans; D008274:Magnesium / Q000494:pharmacology*; D009369:Neoplasms / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology*
D004573:Electrolytes; D001216:Asparagine; D008274:Magnesium; D011188:Potassium
ASPARAGINE/related compounds; MAGNESIUM/pharmacology; NEOPLASMS/metabolism; POTASSIUM/pharmacology